Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHACS: Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
NCT01127295Phase 4Completed
- Sponsor
- Institut Claudius Regaud
- Start
- Jun 2010
- Primary completion
- Dec 2017
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen, letrozole, anastrozole, exemestane in breast cancer, sponsored by Institut Claudius Regaud. Started Jun 2010; status: completed.
02
Drugs
tamoxifenletrozoleanastrozoleexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01127295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127295.